A recent study from our group has shown that the V196A mutation in mouse TRAF1 leads to abrogation of its interaction with cIAP2 in BMDMs and reduced responses to LPS in in vivo models of sepsis and RA.22 The gene discussed is BIRC3; the disease is rheumatoid arthritis.